Bromide

Bromide

SCHEMBL3881994

CC[N+](C)(C)c1ccccc1.[Br-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 4/20 0.57
OPRM1 known ✓ P35372 1/20 0.54
CHRM4 known ✓ P08173 2/20 0.34
CHRM1 known ✓ P11229 2/20 0.34
CHRM3 known ✓ P20309 2/20 0.34
CHRM2 known ✓ P08172 1/20 0.32
TSHR P16473 1/20 0.54
BLM P54132 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
APOBEC3A P31941 1/20 0.48
APOBEC3G Q9HC16 1/20 0.48
TP53 P04637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
DNM1 Q05193 2/20 0.35
CHRNB2 P17787 2/20 0.34
CHRNB4 P30926 2/20 0.34
CHRNA3 P32297 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2575151 0.97 ACHE (0.55) ACHETSHROPRM1BLMSMN1; SMN2
Bromide SCHEMBL2575147 0.97 ACHE (0.55) ACHETSHROPRM1BLMSMN1; SMN2
SCHEMBL2954430 0.97 ACHE (0.56) ACHETSHROPRM1BLMSMN1; SMN2
SCHEMBL7553902 0.95 ACHE (0.54) ACHETSHROPRM1BLMSMN1; SMN2
Water SCHEMBL7548761 0.95 ACHE (0.54) ACHETSHROPRM1BLMSMN1; SMN2
Hydrochloric Acid SCHEMBL11288802 0.95 ACHE (0.57) ACHETSHROPRM1BLMSMN1; SMN2
Fluoride Ion SCHEMBL7548962 0.95 ACHE (0.54) ACHETSHROPRM1BLMSMN1; SMN2
SCHEMBL7553904 0.95 ACHE (0.54) ACHETSHROPRM1BLMSMN1; SMN2
Bromide SCHEMBL2575150 0.93 ACHE (0.52) ACHETSHROPRM1BLMSMN1; SMN2
SCHEMBL11569379 0.90 ACHE (0.50) ACHETSHROPRM1BLMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104419944-B The method that electrochemistry prepares silicon fiml 韩国原子力研究院 2017-06-16 CN claimed
US-9291595-B2 Monitoring method and system of metal ions or oxygen ions applicable to high concentration non-aqueous electrolyte KOREA ATOMIC ENERGY RESEARCH INSTITUTE (KR) 2016-03-22 US claimed
CN-103308588-B Method and system for monitoring metal ions or oxygen ions applicable to high-concentration non-aqueous electrolyte KOREA ATOMIC ENERGY RESEARCH INSTITUTE (KR) 2015-12-23 CN claimed
CN-104419944-A Electrochemical Preparation Method of Silicon Film KOREA ATOMIC ENERGY RES 2015-03-18 CN claimed
US-20150050816-A1 METHOD OF ELECTROCHEMICALLY PREPARING SILICON FILM KOREA ATOMIC ENERGY RESEARCH INSTITUTE (KR) 2015-02-19 US claimed
US-20130264222-A1 MONITORING METHOD AND SYSTEM OF METAL IONS OR OXYGEN IONS APPLICABLE TO HIGH CONCENTRATION NON-AQUEOUS ELECTROLYTE KOREA HYDRO & NUCLEAR POWER CO., LTD. (KR) 2013-10-10 US claimed
CN-103308588-A Method and system for monitoring metal ions or oxygen ions applicable to high-concentration non-aqueous electrolyte KOREA HYDRO & NUCLEAR POWER CO 2013-09-18 CN claimed
EP-2683792-B1 NOVEL ETCHING COMPOSITION FUJIFILM ELECTRONIC MAT USA INC (US) 2019-09-25 EP disclosed
CN-104419944-B The method that electrochemistry prepares silicon fiml 韩国原子力研究院 2017-06-16 CN disclosed
EP-2807289-B1 ETCHING COMPOSITION FUJIFILM ELECTRONIC MATERIALS (US) 2016-09-21 EP disclosed
US-9291595-B2 Monitoring method and system of metal ions or oxygen ions applicable to high concentration non-aqueous electrolyte KOREA ATOMIC ENERGY RESEARCH INSTITUTE (KR) 2016-03-22 US disclosed
CN-103308588-B Method and system for monitoring metal ions or oxygen ions applicable to high-concentration non-aqueous electrolyte KOREA ATOMIC ENERGY RESEARCH INSTITUTE (KR) 2015-12-23 CN disclosed
US-9200372-B2 Passivation composition and process FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2015-12-01 US disclosed
CN-103308588-A Method and system for monitoring metal ions or oxygen ions applicable to high-concentration non-aqueous electrolyte KOREA HYDRO & NUCLEAR POWER CO 2013-09-18 CN disclosed
US-20130122701-A1 Novel Passivation Composition and Process FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2013-05-16 US disclosed
WO-2013059806-A1 Novel Passivation Composition and Process FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2013-04-25 WO disclosed
WO-2012125401-A1 NOVEL ETCHING COMPOSITION FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2012-09-20 WO disclosed
US-20120231632-A1 Novel Etching Composition FUJIFILM CORPORATION (JP) 2012-09-13 US disclosed
US-7560585-B2 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2009-07-14 US disclosed
US-20060128982-A1 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2006-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128982-A1 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate PCCA, CHRNE, CHRNB4 ACHE 1353/4885OPRM1 2792/4885CHRM4 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.